Literature DB >> 12482996

The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.

Won Young Lee1, Moo Il Kang, Ki Hyun Baek, Eun Sook Oh, Ki Won Oh, Kwang Woo Lee, Sun Woo Kim, Choon Choo Kim.   

Abstract

Loss of bone mass is usually detected after bone marrow transplantation (BMT) during the early post-transplant period. However, little is known about the long-term effects of BMT on bone metabolism. We have prospectively investigated 11 patients undergoing BMT. Bone mineral density (BMD) was measured before BMT, and 1, 2, and 3 yr after BMT. Serum markers of bone turnover were serially measured before BMT and 1, 2, 3, 4, and 12 weeks, 6 months, and 1 yr after BMT. The mean change in the lumbar spine (L2-4) BMD, calculated as the percent change from the baseline to the level at 1, 2, and 3 yr was -4.7% (NS), -1.1% (NS), and +6.4% (p<0.05), respectively. The mean change in the total proximal femur BMD from the baseline to the level at 1, 2, and 3 yr was -8.5% (p<0.01), -8.7% (p<0.05) and -5.6% (p<0.05), respectively. In summary, there was little decline in lumbar BMD at 1 yr following BMT and gradual recovery until 3 yr. In contrast, femoral BMD decreased much more than the lumbar area at 1 yr and did not recover until 3 yr. The mechanism of skeletal site-selective differences in the changes of BMD needs to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482996      PMCID: PMC3054966          DOI: 10.3346/jkms.2002.17.6.749

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Teresa S Miceli; Kathleen Colson; Beth M Faiman; Kena Miller; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

2.  Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.

Authors:  Nataliya P Buxbaum; Cemre Robinson; Ninet Sinaii; Alexander Ling; Lauren M Curtis; Steven Z Pavletic; Kristin Baird; Maya B Lodish
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-01       Impact factor: 5.742

Review 3.  Transplantation osteoporosis.

Authors:  Peter R Ebeling
Journal:  Curr Osteoporos Rep       Date:  2007-03       Impact factor: 5.096

4.  Bone loss after allogeneic haematopoietic stem cell transplantation: a pilot study on the use of zoledronic Acid.

Authors:  Andreas Hausmann; Wolfgang Hill; Hans Joachim Stemmler; Georg Ledderose; Andrea Baur-Melnyk; Susanne Fritsch; Johanna Ullmann; Hans-Jochem Kolb; Sandra Geiger; Johanna Tischer
Journal:  Chemother Res Pract       Date:  2012-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.